Mitochondrial fusion heterogeneity drives bidirectional tumor phenotypic transition in combined hepatocellular–cholangiocarcinoma
Proceedings of the National Academy of Sciences · 05.05.2026 · 123 (18)
DOI: 10.1073/pnas.2521310123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 28.04.2026. Verfasst von Lin Chen und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Department of Physiology and Pathophysiology, Fourth Military…. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma, Mitochondrial Dynamics. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Shaanxi Province Science Fund for Distinguished Young Scholars, Key Research and Development Program of Shaanxi Province.
Abstract (Originalsprache)
Dysregulation of mitochondrial dynamics modulates malignant cell fate; however, the substantial heterogeneity in mitochondrial dynamics among tumor cells within individual tumor nodules and the resultant functional consequences remain inadequately characterized. In this study, we induced mosaic impairment of mitochondrial fusion in mouse liver under tumorigenic conditions and unexpectedly identified the formation of combined hepatocellular-cholangiocarcinoma (cHC), a monoclonal tumor displaying features of both hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Restoration of the mitochondrial fusion protein MFN1 effectively suppressed cHC development. Analysis of human cHC samples revealed that ICC-like cells exhibit more pronounced mitochondrial fusion impairment compared to HCC-like cells. Mechanistically, increasing impairment of mitochondrial fusion resulted in a dose-dependent elevation of reactive oxygen species (ROS). Low levels of ROS upregulated HNF4α, promoting HCC-like differentiation, whereas high ROS levels activated HES1, facilitating ICC-like differentiation. Collectively, these results demonstrate that heterogeneity in mitochondrial dynamics is a critical determinant of cHC path-ogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Department of Physiology and Pathophysiology, Fourth Military Medical University, Xi'an 710032, China.
- Shandong Provincial Engineering Laboratory of Novel Pharmaceutical Excipients, Sustained and Controlled Release Preparations, College of Health and Medicine, Dezhou University, Dezhou 253023, China.
- Department of Hepatobiliary Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
- Department of Health Statistics, School of Preventive Medicine, Fourth Military Medical University, Xi'an 710032, China.
- Department of Ultrasound Diagnostics, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
- National Demonstration Center for Experimental Basic Medical Science Education, Fourth Military Medical University, Xi'an 710032, China.
ORCID-Profile: Lin Chen, Dalin Wang, Dan Wu, Xingchen Wang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Shaanxi Province Science Fund for Distinguished Young Scholars
- Key Research and Development Program of Shaanxi Province
- "Rapid Response" Research Projects of FMMU
- “Rapid Response” Research Projects of FMMU
Zitieren
APA
Chen, L., Wang, D., Qin, W., Wang, G., Wu, D., Li, J., Wang, X., Wang, Y., Sun, X., Zhao, J., Guo, S., Ji, L., Tian, J., Ding, R., Nie, Y., Xing, J., & Huang, Q. (2026). Mitochondrial fusion heterogeneity drives bidirectional tumor phenotypic transition in combined hepatocellular–cholangiocarcinoma. Proceedings of the National Academy of Sciences, 123(18). https://doi.org/10.1073/pnas.2521310123
Vancouver
Chen L, Wang D, Qin W, Wang G, Wu D, Li J, et al. Mitochondrial fusion heterogeneity drives bidirectional tumor phenotypic transition in combined hepatocellular–cholangiocarcinoma. Proceedings of the National Academy of Sciences. 2026;123(18). doi:10.1073/pnas.2521310123
BibTeX
@article{Chen2026,
author = {Chen, Lin and Wang, Dalin and Qin, Weidong and Wang, Gang and Wu, Dan and Li, Jiaying and Wang, Xingchen and Wang, Yinping and Sun, Xiacheng and Zhao, Jing and Guo, Shanshan and Ji, Lele and Tian, Jiming and Ding, Rui and Nie, Yongzhan and Xing, Jinliang and Huang, Qichao},
title = {Mitochondrial fusion heterogeneity drives bidirectional tumor phenotypic transition in combined hepatocellular–cholangiocarcinoma},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {18},
doi = {10.1073/pnas.2521310123}
}
EUVIMED